News
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
Zacks Investment Research on MSN1h
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on ItNovavax (NVAX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
MedPage Today on MSN2dOpinion
An Uncertain Vaccines Market Keeps Getting DicierUnpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...
Uncertainty now dominates the COVID vaccine outlook after official recommendations were stripped for a variety of groups.
Washingtonian on MSN3d
Can Your Child Get the Covid-19 Vaccine? Can You?Vaccination rates across the country have continued to fall since the height of the pandemic, but the coronavirus never ...
The FDA approved Moderna’s lower-dose COVID-19 vaccine, but only for individuals aged 65 years or older and people aged 12 to ...
What to Expect on MSN6d
Should Pregnant Women Still Get the COVID-19 Vaccine?Here’s everything parents should know about the COVID-19 vaccines for pregnant women, including why it's still an important way to protect yourself and your baby. Should I get t ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback